Related Experiment Videos
Ganglion cell losses underlying visual field defects from experimental glaucoma
R S Harwerth1, L Carter-Dawson, F Shen
1College of Optometry, University of Houston, Texas 77204-6052, USA. rharwerth@uh.edu
Investigative Ophthalmology & Visual Science
|September 7, 1999
Summary
Glaucoma damages vision by causing ganglion cell loss. Current visual field tests underestimate cell loss until significant damage has occurred, making early detection difficult.
Area of Science:
- Ophthalmology
- Neuroscience
- Vision Science
Background:
- Glaucoma is a leading cause of irreversible blindness.
- Retinal ganglion cells are crucial for vision and are progressively lost in glaucoma.
- Accurate assessment of ganglion cell loss is vital for early glaucoma diagnosis and management.
Purpose of the Study:
- To investigate the relationship between retinal ganglion cell loss and visual field defects in experimental glaucoma.
- To determine if perimetry stimuli type affects the detection of early glaucomatous damage.
Main Methods:
- Unilateral experimental glaucoma was induced in 10 rhesus monkeys using argon laser trabeculoplasty.
- Behavioral perimetry and retinal histology were performed to quantify visual field defects and ganglion cell loss.
- The correlation between cell loss percentage and visual sensitivity loss was analyzed for various perimetry stimuli.
Main Results:
- A nonlinear relationship was observed between ganglion cell loss and visual sensitivity loss.
- Significant visual sensitivity loss was minimal until 30-50% of ganglion cells were lost.
- The neural-sensitivity relationship was similar for white and monochromatic perimetry stimuli.
Conclusions:
- Current perimetry methods are insensitive to early glaucoma, failing to estimate ganglion cell loss until substantial cell death has occurred.
- There is significant variability in cell loss for mild visual field defects, especially near the fovea.
- Monochromatic stimuli do not appear to offer an advantage over white stimuli for detecting glaucoma based on ganglion cell loss.